Narayana Hrudayalaya Ltd
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 43,534 Cr.
- Current Price ₹ 2,130
- High / Low ₹ 2,372 / 1,171
- Stock P/E 101
- Book Value ₹ 107
- Dividend Yield 0.18 %
- ROCE 19.4 %
- ROE 21.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 43.9% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 19.9%
Cons
- Stock is trading at 20.2 times its book value
- The company has delivered a poor sales growth of 9.90% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,076 | 1,308 | 1,470 | 1,646 | 1,848 | 2,077 | 2,239 | 1,655 | 2,412 | 2,965 | 3,266 | 3,590 | |
960 | 1,182 | 1,295 | 1,427 | 1,664 | 1,881 | 1,971 | 1,676 | 2,146 | 2,471 | 2,656 | 2,919 | |
Operating Profit | 115 | 126 | 175 | 219 | 184 | 196 | 268 | -21 | 266 | 494 | 609 | 672 |
OPM % | 11% | 10% | 12% | 13% | 10% | 9% | 12% | -1% | 11% | 17% | 19% | 19% |
25 | 10 | 2 | 14 | 16 | 17 | 19 | 71 | 104 | 95 | 120 | 142 | |
Interest | 29 | 38 | 23 | 17 | 26 | 43 | 55 | 48 | 45 | 55 | 65 | 88 |
Depreciation | 55 | 64 | 67 | 68 | 78 | 91 | 128 | 123 | 119 | 139 | 161 | 169 |
Profit before tax | 56 | 34 | 86 | 147 | 95 | 79 | 104 | -121 | 206 | 395 | 503 | 557 |
Tax % | 36% | 38% | 34% | 35% | 39% | 37% | 35% | -35% | 35% | 33% | 16% | 23% |
36 | 21 | 57 | 95 | 58 | 50 | 68 | -79 | 134 | 266 | 425 | 431 | |
EPS in Rs | 1,107.25 | 1.05 | 2.77 | 4.65 | 2.86 | 2.45 | 3.31 | -3.85 | 6.54 | 13.00 | 20.77 | 21.10 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 41% | 30% | 0% | 15% | 19% | 19% | 21% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 10% |
3 Years: | 14% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 35% |
5 Years: | 44% |
3 Years: | 47% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 54% |
3 Years: | 52% |
1 Year: | 88% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 16% |
3 Years: | 22% |
Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Reserves | 569 | 595 | 753 | 854 | 916 | 963 | 962 | 885 | 1,021 | 1,264 | 1,636 | 1,981 |
321 | 289 | 152 | 120 | 491 | 499 | 607 | 551 | 533 | 644 | 1,011 | 1,595 | |
237 | 216 | 274 | 309 | 383 | 410 | 449 | 462 | 528 | 664 | 645 | 718 | |
Total Liabilities | 1,128 | 1,300 | 1,383 | 1,487 | 1,995 | 2,077 | 2,222 | 2,103 | 2,285 | 2,777 | 3,496 | 4,499 |
626 | 651 | 650 | 682 | 973 | 949 | 1,159 | 1,070 | 1,094 | 1,358 | 1,480 | 2,341 | |
CWIP | 12 | 9 | 13 | 52 | 30 | 56 | 3 | 5 | 23 | 32 | 34 | 27 |
Investments | 51 | 241 | 334 | 354 | 561 | 597 | 619 | 645 | 661 | 678 | 1,021 | 1,166 |
438 | 399 | 386 | 399 | 431 | 475 | 441 | 382 | 507 | 709 | 962 | 964 | |
Total Assets | 1,128 | 1,300 | 1,383 | 1,487 | 1,995 | 2,077 | 2,222 | 2,103 | 2,285 | 2,777 | 3,496 | 4,499 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
164 | 61 | 177 | 218 | 196 | 208 | 286 | 123 | 246 | 516 | 542 | 523 | |
-172 | -192 | -130 | -162 | -446 | -137 | -129 | -12 | -117 | -621 | -761 | -754 | |
5 | 127 | -2 | -32 | 226 | -11 | -170 | -114 | -57 | 65 | 237 | 391 | |
Net Cash Flow | -3 | -4 | 46 | 25 | -24 | 61 | -12 | -3 | 72 | -40 | 19 | 160 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 45 | 40 | 34 | 31 | 37 | 28 | 24 | 34 | 26 | 22 | 21 | 25 |
Inventory Days | 63 | 55 | 46 | 42 | 41 | 36 | 24 | 19 | 18 | 17 | 28 | 19 |
Days Payable | 206 | 136 | 142 | 161 | 179 | 165 | 171 | 237 | 177 | 211 | 192 | 168 |
Cash Conversion Cycle | -98 | -41 | -62 | -88 | -102 | -101 | -124 | -184 | -133 | -172 | -143 | -124 |
Working Capital Days | -12 | 6 | 3 | -1 | -5 | -15 | -23 | -34 | -23 | -27 | -23 | 12 |
ROCE % | 9% | 7% | 11% | 15% | 9% | 8% | 9% | -4% | 15% | 23% | 23% | 19% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - Scheduled investor meeting with Franklin Templeton on July 3, 2025, via virtual one-to-one session.
- Closure of Trading Window 2d
-
Rumour verification - Regulation 30(11)
26 Jun - Clarifies prior disclosures on ₹246cr land deals and ₹400cr investment; no new info shared.
-
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
25 Jun - Received no-objection letters from BSE and NSE for merger scheme with Meridian Medical Research.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25 Jun - Of schedule of investors meeting to be held on June 27, 2025
Annual reports
Concalls
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptNotesPPT
Hospital Portfolio[1][2]
- India: 19 owned/operated hospitals, 2 heart centers, 18 clinics, and dialysis centers.
- Cayman Islands: 1 hospital.
** - Total:** 40 healthcare facilities with 5,789 operational beds (including Cayman).